Everest Organics Quarterly Results for Trading Insights
EVERESTO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-1 Cr
QMarch 2025
Everest Organics Quarterly Results Key Highlights
- Revenue of ₹160 Cr in March 2025 (+0.0% vs March 2025, -19.2% vs March 2024)
- Net Profit of ₹-1 Cr in March 2025 (+0.0% vs March 2025)
- EBITDA of ₹8 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 5.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹-2.97 in March 2025 (+0.0% vs March 2025)
Everest Organics Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 189 | 160 | 198 | 190 | 202 | 18.1% | - |
| Net Profit (₹ Cr) | 7 | -1 | 0 | 0 | 1 | - | - |
| EBITDA (₹ Cr) | 18 | 8 | 12 | 8 | 9 | - | - |
| EPS (₹) | 7.10 | -2.97 | 0.17 | -0.23 | 1.43 | - | - |
| Operating Margin (%) | 9.0% | 5.0% | 6.0% | 1.0% | 3.0% | - | - |
Everest Organics Share Price Trend Around Quarterly Results
Visualize Everest Organics's 1-year price movement across quarterly results — ideal for logging trades in Everest Organics share price
chart using Tickjournal. All values in ₹.
Related Pages for Everest Organics
Additional stock information and data for EVERESTO
Revenue Trend (₹ Cr)
March 2023
190
March 2024
198
March 2025
160
2026
189
Net Profit Trend (₹ Cr)
March 2023
0
March 2024
0
March 2025
-1
2026
7
Operating Margin Trend (%)
March 2023
1.0%
March 2024
6.0%
March 2025
5.0%
2026
9.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Everest Organics quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores